1 figure, 2 tables omitted
Deaths caused by drug poisoning of unintentional and undetermined intent
are an increasing problem in Utah and elsewhere in the United States.1 To characterize the trend in drug-poisoning deaths
in Utah, CDC and the Utah Department of Health analyzed medical examiner (ME)
data for 1991-1998 and 1999-2003. This report summarizes the results of that
analysis, which determined that, during 1991-2003, the number of Utah residents
dying from all drug poisoning increased nearly fivefold, from 79 deaths in
1991 (rate: 4.4 per 100,000 population) to 391 deaths in 2003 (rate: 16.6).
This increase has been largely the result of the tripling of the rate (from
1.5 during 1991-1998 to 4.4 during 1999-2003) in poisoning deaths of unintentional
or undetermined intent caused by non-illicit drugs (i.e., medications that
can be legally prescribed) (Figure). Further study is needed to understand
these trends and to develop strategies to prevent deaths of unintentional
or undetermined intent from non-illicit drug poisoning.
Utah has a centralized statewide ME system with statute-specified jurisdiction
that includes drug-related deaths. The ME database used for these analyses
contains decedent demographics; data on the circumstances, causes, and manner
of death; examination results; and laboratory findings.2 A
drug-poisoning death was defined as the death of a Utah resident with drug
poisoning listed as cause of death. Deaths were identified by searching the
ME database for a drug-poisoning–related keyword (e.g., drug, overdose,
poisoning, toxicity, or intoxication). Deaths identified by that search were
each reviewed to verify that they met the case definition. Each death was
classified as related to illicit drugs only, to non-illicit drugs only, or
to both illicit and non-illicit drugs. Each death was also classified as (1)
intentional (i.e., suicide or homicide) or (2) unintentional (e.g., nonsuicidal,
nonhomicidal, or natural deaths) or undetermined (i.e., cause unknown). Decedent
characteristics, annual numbers and rates of drug-poisoning deaths, and trends
in drug-poisoning deaths were analyzed.
Death rates were calculated by using denominators from the Utah Population
Estimate Query System.3 To examine a possible
association between overweight or obesity and drug-poisoning death, which
had been noted anecdotally by Utah MEs, decedents were categorized based on
body mass index (BMI).4 For analysis of this
association, population estimates were based on results from the Utah Behavioral
Risk Factor Surveillance System (Unpublished data, 2003). To examine the effect
of urban versus rural residence, rates were calculated separately for four
urban counties (Davis, Weber, Salt Lake, and Utah counties) that contain approximately
75% of the Utah population, and for the remaining counties in the state, which
were classified as rural.3
During 1991-2003, a total of 2,396 drug-poisoning deaths were identified,
of which 947 were caused by illicit drugs only, 1,277 by non-illicit drugs
only, and 172 by a combination of illicit and non-illicit drugs. Alcohol was
also implicated in 22% of drug-poisoning deaths; however, alcohol was not
considered a drug for these analyses. The largest increase in annual drug-poisoning
deaths (from 55 in 1991 to 237 in 2003) was attributed to non-illicit drugs.
Illicit drug-poisoning deaths increased each year during 1991-1998 and then
decreased to 92 deaths in 2003. Deaths resulting from a combination of illicit
and non-illicit drugs increased gradually during 1991-2002, then increased
substantially, from 15 in 2002 to 35 in 2003.
Among deaths attributed to non-illicit drugs, during 1991-2003, a total
of 733 were classified as of unintentional or undetermined intent; because
these deaths had increased substantially since 1999, they were examined for
the periods 1991-1998 and 1999-2003. Further analyses focused on possible
associations of selected characteristics of the decedents and the drug types
involved in their deaths.
Death rates varied by age group and were highest for adults aged 25-54
years. Comparing cumulative 1991-1998 data with those for 1999-2003, the greatest
numeric increase in deaths (from 42 to 142) occurred among adults aged 45-54
years. Death rates per 100,000 population were higher for men than women during
both periods (men: 1.86 and 4.90; women: 1.08 and 3.90), but the percentage
increase in rates from 1991-1998 to 1999-2003 was greater for women than men
(261% versus 163%). More deaths occurred in urban areas than rural areas during
both periods (186 versus 45, during 1991-1998; 362 versus 140, during 1999-2003);
however, the increase in death rate from 1991-1998 to 1999-2003 was greater
in rural areas than urban areas (317% versus 171%). In addition, although
substantial increases in death rates occurred from 1991-1998 to 1999-2003
in each BMI category, rates were substantially higher during 1999-2003 among
persons who were overweight (5.26 per 100,000 population) or obese (14.25),
compared with persons who were not overweight or obese (3.61).
Methadone and other prescription narcotics accounted for most of the
increase from 1991-1998 to 1999-2003 in non-illicit drug-poisoning deaths
of unintentional or undetermined intent. Comparing these periods, deaths attributable
to methadone increased from two to 33 per year, and deaths attributable to
other prescription narcotics (principally oxycodone and hydrocodone) increased
from 10 to 48 per year. From 1991-1998 to 1999-2003, the proportions of these
deaths that involved alcohol or antidepressants decreased from 32.9% and 14.7%,
respectively, to 19.9% and 6.6%.
EM Caravati, MD, Utah Poison Control Center, Salt Lake City; T Grey,
MD, B Nangle, PhD, RT Rolfs, MD, Utah Dept of Health. CA Peterson-Porucznik,
PhD, EIS Officer, CDC.
The findings in this report indicate that deaths attributed to drug
poisoning have increased in Utah for more than a decade; however, the characteristics
of these deaths have changed since 1999, when deaths caused by non-illicit
drugs began to increase substantially. In 2003, the typical drug-poisoning
decedent in Utah was overweight or obese, aged 25-54 years, had died from
the effects of non-illicit drugs, and was less likely than previously to be
male and to live in an urban area.
The findings in this report are subject to at least three limitations.
First, analysis was limited to deaths investigated by the Utah State Office
of the Medical Examiner. Although this office has jurisdiction over all deaths
thought to be drug-related, some drug-poisoning deaths might not have been
properly reported and, therefore, might have been excluded from analysis.
Second, BMI values for the decedents were based on measurements made by the
ME. The measured body weight at postmortem examination might have been less
than the decedent’s usual body weight when alive. In addition, the denominator
used for death rate calculations was based on self-reported data from a telephone
survey in which respondents might underreport weight. The combined effects
of these two potential biases are uncertain. Finally, whether being overweight
or obese is a risk factor for fatal drug poisoning or the result of greater
use of these drugs by overweight persons cannot be determined from the data.
The Drug Enforcement Administration collects information regarding the
movement of controlled substances from manufacture through commercial distribution
channels by using the Automation of Reports and Consolidated Orders System
(ARCOS).5 From 1997 to 2002, the amount of
drugs distributed to Utah and the United States (in grams per 100,000 population)
increased substantially for several of the prescription drugs described in
this report, including methadone (Utah: from 269 g to 1,703 g; United States:
194 g to 954 g), oxycodone (Utah: 1,848 g to 9,804 g; United States: 1,668
g to 8,056 g), and hydrocodone (Utah: 4,754 g to 8,122 g; United States: 3,249
g to 6,777 g). The numbers of drug-poisoning deaths attributed to each of
these drugs increased at a greater rate than the supplies of the drugs in
Utah. In addition, from 1997 to 2002, the codeine supply declined (Utah: from
7,746 g to 5,179 g; United States: 9,396 g to 8,149 g), possibly suggesting
a prescription preference for newer pain-relieving drugs.
The sixfold increase in the methadone supply in Utah and fivefold increase
in the United States were not the result of expansion of addiction treatment
programs; ARCOS does not track drugs distributed through such programs. Methadone
is also used to control pain and can be prescribed by physicians for pain
management. Review of ME investigations into methadone deaths during 1996-2000
revealed previous methadone prescriptions for 48% (17 of 35) of decedents.
A valid methadone prescription at time of death was found for 40% (14 of 35)
of decedents. Of those with a valid prescription, seven (50%) were taking
methadone for the first time (range: zero to 17 previous prescriptions) when
Sources of decedents’ drugs cannot always be determined from ME
data. The narcotics associated with a drug-poisoning death might have been
prescribed for pain, acquired illegally, or (in the case of methadone) obtained
from an addiction treatment program. Further research is needed to investigate
the proportion of deaths that occurred among legitimate users of prescription
medications, and to identify risk factors that might increase the likelihood
of drug-poisoning deaths for patients using prescription medications. Other
state health departments that track drug-poisoning deaths should conduct their
own analyses of unintentional or undetermined drug-poisoning deaths caused
by non-illicit drugs. Steps should be taken to ensure safe use of non-illicit,
pain-relieving medications while more information regarding factors contributing
to deaths is collected. Such steps should include increased education for
both health-care providers and their patients.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.